T 2171/21 (Anti-IL-17 antibody for treating ankylosing spondylitis/NOVARTIS) of 07.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T217121.20231107
- Date of decision
- 7 November 2023
- Case number
- T 2171/21
- Online on
- 13 December 2023
- Petition for review of
- -
- Application number
- 16163440.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 076
- Application title
- Methods of treating ankylosing spondylitis using anti-IL-17 antibodies
- Applicant name
- Novartis AG
- Opponent name
- Dr. Reddy's Laboratories Limited
Strawman Limited
Boult Wade Tennant LLP - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 76(1)
- Keywords
- Amendments - extension beyond the content of the application as filed (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.